Catalyst Wire Dossier Catalyst Wire Dossier

CV regimen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CV regimen, covering 2023-07-24 to 2023-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas [Phase 2]

See pricing